Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Aurobindo Pharma cholesterol drug gets final USFDA nod

      Aurobindo Pharma cholesterol drug gets final USFDA nod

      savita thakur thakur7 May 2016 11:49 AM IST
      New Delhi : Aurobindo Pharma has received final approval from the USFDA to manufacture and market Fenofibrate tablets, used for the treatment of high...
      Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnostic Assays in Oncology

      Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnostic Assays in Oncology

      savita thakur thakur6 May 2016 1:45 PM IST
      Cambridge : Foundation Medicine, Inc. announced an agreement with AstraZeneca to develop companion diagnostic assays to facilitate personalized...
      Siemens Healthcare Rebrands as Healthineers

      Siemens Healthcare Rebrands as Healthineers

      savita thakur thakur6 May 2016 1:30 PM IST
      Frankfurt : German industrial group Siemens rebranded its healthcare business on Wednesday following the unit's carve-out into a separate legal entity...
      Sanofi, Amgen Cholesterol Drugs win UK Backing After Price Cuts

      Sanofi, Amgen Cholesterol Drugs win UK Backing After Price Cuts

      savita thakur thakur6 May 2016 1:27 PM IST
      London : Two rival cholesterol-lowering injections from Sanofi and Amgen have been recommended by Britain's healthcare cost watchdog after the...
      Drug Pricing Regime Needs to be Predictable,Transparent:Sanofi

      Drug Pricing Regime Needs to be Predictable,Transparent:Sanofi

      savita thakur thakur6 May 2016 9:36 AM IST
      New Delhi : Government must not place the entire burden of access to healthcare on the pharmaceutical industry alone, Sanofi India has said while...
      Lupin reintroduces Methergine® Oral Tablets in the US for postpartum hemorrhage

      Lupin reintroduces Methergine® Oral Tablets in the US for postpartum hemorrhage

      savita thakur thakur5 May 2016 1:10 PM IST
      Mumbai : Pharma Major Lupin Limited and its US subsidiary, Lupin Pharmaceuticals, Inc. (collectively Lupin) have announced the re-introduction of...
      No Plea From Pharma Industry to Resolve Issues With USFDA: Govt

      No Plea From Pharma Industry to Resolve Issues With USFDA: Govt

      savita thakur thakur5 May 2016 1:06 PM IST
      New Delhi : Domestic pharmaceutical industry has not approached the government for early intervention to resolve regulatory issues faced by them in...
      Sun Pharma, ICGEB to Develop Botanical Drug for Dengue

      Sun Pharma, ICGEB to Develop Botanical Drug for Dengue

      savita thakur thakur5 May 2016 1:06 PM IST
      New Delhi : Sun Pharmaceutical Industries signed a pact with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel...
      Late-stage trial clears Regenerons Osteoarthritis pain drug

      Late-stage trial clears Regeneron's Osteoarthritis pain drug

      savita thakur thakur4 May 2016 4:21 PM IST
      Drugmaker Regeneron Pharmaceuticals Inc said on Monday its experimental drug to treat moderate-to-severe osteoarthritis pain was successful in a...
      Johnson & Johnson to Pay $55 Million as it loses Talc-Powder Trial

      Johnson & Johnson to Pay $55 Million as it loses Talc-Powder Trial

      savita thakur thakur4 May 2016 3:49 PM IST
      Johnson & Johnson was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for...
      Trustees handed over charge of Lilavati Hospital by interim board

      Trustees handed over charge of Lilavati Hospital by interim board

      savita thakur thakur4 May 2016 3:44 PM IST
      Mumbai : In keeping with a Supreme Court directive, the Chairman of interim board of trustees of multi-speciality Lilavati Hospital, Justice (Retd) J...
      Biogen to focus on core neuro business while spinning off Hemophilia drug trade

      Biogen to focus on core neuro business while spinning off Hemophilia drug trade

      savita thakur thakur4 May 2016 9:19 AM IST
      Biogen Inc plans to spin off its hemophilia drug business as a publicly traded company, leaving the drugmaker to focus on developing drugs for...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok